These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1348320)

  • 41. [Protective effect of lipid A monoclonal antibody against burn sepsis in rats].
    Xiao H; Fu W; Xiao G
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1996 May; 12(3):167-70. PubMed ID: 9206124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Monoclonal antibodies in the treatment of sepsis caused by Gram-negative microorganisms].
    Otero AJ; Linares M
    Rev Cubana Med Trop; 1998; 50(1):31-5. PubMed ID: 9842265
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Preventive interruption of the administration of HA-1A monoclonal antibody against endotoxin].
    Torrabadella de Reynoso P; Trilla A; Salgado A; Ribas J
    Med Clin (Barc); 1993 Apr; 100(13):518. PubMed ID: 8479241
    [No Abstract]   [Full Text] [Related]  

  • 44. The role of monoclonal antibodies in the management of gram-negative sepsis. Experience with the E5 antibody.
    Gorelick KJ; Chmel H
    Infect Dis Clin North Am; 1991 Dec; 5(4):899-913. PubMed ID: 1783775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of a monoclonal anti-endotoxin antibody (E5) in endotoxin lung injury rat model: preliminary report].
    Kimura Y; Abo S; Kitamura M; Izumi K; Minamiya Y; Sato H; Saito S
    Nihon Geka Gakkai Zasshi; 1994 Feb; 95(2):132. PubMed ID: 8121387
    [No Abstract]   [Full Text] [Related]  

  • 46. [Meningococcal infection].
    Shipilova OG
    Med Sestra; 1984 Oct; 43(10):12-6. PubMed ID: 6569965
    [No Abstract]   [Full Text] [Related]  

  • 47. MOF induced by meningococcal sepsis: successful outcome after intensive multidisciplinary approaches.
    Valbonesi M; Pallavicini FB; Cannella G; Zinno E; Patrone F; Carlier P; Dejana A; Morelli F
    Transfus Apher Sci; 2005 Aug; 33(1):75-7. PubMed ID: 16009597
    [No Abstract]   [Full Text] [Related]  

  • 48. Meningococcal septicaemia and meningitis: a rising tide.
    Raman GV
    Br Med J (Clin Res Ed); 1988 Apr; 296(6630):1141-2. PubMed ID: 3132239
    [No Abstract]   [Full Text] [Related]  

  • 49. Meningococcal septicaemia treated with combined plasmapheresis and leucapheresis or with blood exchange.
    Pedersen RS; Pedersen OL; Nielsen I; Stengaard-Petersen K
    Br Med J (Clin Res Ed); 1984 Jul; 289(6439):254-5. PubMed ID: 6430430
    [No Abstract]   [Full Text] [Related]  

  • 50. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group.
    Greenman RL; Schein RM; Martin MA; Wenzel RP; MacIntyre NR; Emmanuel G; Chmel H; Kohler RB; McCarthy M; Plouffe J
    JAMA; 1991 Aug; 266(8):1097-102. PubMed ID: 1865542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Production of monoclonal antibodies against Neisseria meningitidis using popliteal lymph nodes and in vivo/in vitro immunization: prevalence study of new monoclonal antibodies in greater São Paulo, Brazil.
    Belo EF; Ferraz AS; Coutinho LM; Oliveira AP; Carmo AM; Tunes CF; Ferreira T; Ito AY; Machado MS; De L Franco D; De Gaspari EN
    Hybridoma (Larchmt); 2007 Oct; 26(5):302-10. PubMed ID: 17979546
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of a recombinant endotoxin-neutralizing protein with a human monoclonal antibody to endotoxin for the treatment of Escherichia coli sepsis in rats.
    Kuppermann N; Nelson DS; Saladino RA; Thompson CM; Sattler F; Novitsky TJ; Fleisher GR; Siber GR
    J Infect Dis; 1994 Sep; 170(3):630-5. PubMed ID: 8077721
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of penicillin and chloramphenicol on the growth and endotoxin release by N. meningitidis.
    Mellado MC; Rodríguez-Contreras R; Mariscal A; Luna JD; Delgado Rodríguez M; Galvez-Vargas R
    Epidemiol Infect; 1991 Apr; 106(2):283-8. PubMed ID: 1902182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monoclonal antibody therapy for gram-negative sepsis: principles, applications, and controversies.
    Mehra IV; Gottlieb JE; Nash DB
    Pharmacotherapy; 1993; 13(2):128-34. PubMed ID: 8469619
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Immunotherapy using the anti-endotoxin antibody HA-1A in patients with sepsis syndrome; good results in relation to treatment with placebo].
    Wortel CH; von der Möhlen MA; van Deventer SJ; Schipper HG; Lorijn RH; ten Cate JW
    Ned Tijdschr Geneeskd; 1993 Feb; 137(7):350-4. PubMed ID: 8437633
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Meningococcemia.
    Litter L
    Conn Med; 1967 Dec; 31(12):844-7. PubMed ID: 6080757
    [No Abstract]   [Full Text] [Related]  

  • 57. Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels.
    Wortel CH; von der Möhlen MA; van Deventer SJ; Sprung CL; Jastremski M; Lubbers MJ; Smith CR; Allen IE; ten Cate JW
    J Infect Dis; 1992 Dec; 166(6):1367-74. PubMed ID: 1431255
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extracorporeal life support for children with meningococcal septicaemia.
    Luyt DK; Pridgeon J; Brown J; Peek G; Firmin R; Pandya HC
    Acta Paediatr; 2004 Dec; 93(12):1608-11. PubMed ID: 15841769
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-endotoxin monoclonal antibodies.
    Warren HS; Danner RL; Munford RS
    N Engl J Med; 1992 Apr; 326(17):1153-7. PubMed ID: 1552919
    [No Abstract]   [Full Text] [Related]  

  • 60. Anti-endotoxin monoclonal antibodies.
    Ziegler EJ; Smith CR
    N Engl J Med; 1992 Apr; 326(17):1165. PubMed ID: 1552929
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.